296 related articles for article (PubMed ID: 30144040)
1. The potential role for infections in the pathogenesis of autoimmune Addison's disease.
Hellesen A; Bratland E
Clin Exp Immunol; 2019 Jan; 195(1):52-63. PubMed ID: 30144040
[TBL] [Abstract][Full Text] [Related]
2. The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: the major autoantigen in autoimmune Addison's disease.
Bratland E; Bredholt G; Mellgren G; Knappskog PM; Mozes E; Husebye ES
J Autoimmun; 2009 Aug; 33(1):58-67. PubMed ID: 19329278
[TBL] [Abstract][Full Text] [Related]
3. Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison's disease: comparison of immunofluorescence and immunoprecipitation assays.
Betterle C; Volpato M; Pedini B; Chen S; Smith BR; Furmaniak J
J Clin Endocrinol Metab; 1999 Feb; 84(2):618-22. PubMed ID: 10022426
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure.
Chen S; Sawicka J; Betterle C; Powell M; Prentice L; Volpato M; Rees Smith B; Furmaniak J
J Clin Endocrinol Metab; 1996 May; 81(5):1871-6. PubMed ID: 8626850
[TBL] [Abstract][Full Text] [Related]
5. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease.
Betterle C; Volpato M; Rees Smith B; Furmaniak J; Chen S; Zanchetta R; Greggio NA; Pedini B; Boscaro M; Presotto F
J Clin Endocrinol Metab; 1997 Mar; 82(3):939-42. PubMed ID: 9062510
[TBL] [Abstract][Full Text] [Related]
6. T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency.
Bratland E; Skinningsrud B; Undlien DE; Mozes E; Husebye ES
J Clin Endocrinol Metab; 2009 Dec; 94(12):5117-24. PubMed ID: 19890026
[TBL] [Abstract][Full Text] [Related]
7. Adrenal autoantibodies and organ-specific autoimmunity in patients with Addison's disease.
Söderbergh A; Winqvist O; Norheim I; Rorsman F; Husebye ES; Dolva O; Karlsson FA; Kämpe O
Clin Endocrinol (Oxf); 1996 Oct; 45(4):453-60. PubMed ID: 8959085
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune Addison's disease--evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency.
Furmaniak J; Kominami S; Asawa T; Wedlock N; Colls J; Smith BR
J Clin Endocrinol Metab; 1994 Nov; 79(5):1517-21. PubMed ID: 7962352
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody responses in autoimmune ovarian insufficiency and in Addison's disease are IgG1 dominated and suggest a predominant, but not exclusive, Th1 type of response.
Brozzetti A; Marzotti S; La Torre D; Bacosi ML; Morelli S; Bini V; Ambrosi B; Giordano R; Perniola R; De Bellis A; Betterle C; Falorni A;
Eur J Endocrinol; 2010 Aug; 163(2):309-17. PubMed ID: 20498138
[TBL] [Abstract][Full Text] [Related]
10. The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease.
Hellesen A; Edvardsen K; Breivik L; Husebye ES; Bratland E
Clin Exp Immunol; 2014 Jun; 176(3):351-62. PubMed ID: 24666275
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune Addison's disease.
Saverino S; Falorni A
Best Pract Res Clin Endocrinol Metab; 2020 Jan; 34(1):101379. PubMed ID: 32063488
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease.
Uibo R; Aavik E; Peterson P; Perheentupa J; Aranko S; Pelkonen R; Krohn KJ
J Clin Endocrinol Metab; 1994 Feb; 78(2):323-8. PubMed ID: 8106620
[TBL] [Abstract][Full Text] [Related]
13. The autoimmune basis of adrenocortical destruction in Addison's disease.
Winqvist O; Söderbergh A; Kämpe O
Mol Med Today; 1996 Jul; 2(7):282-9. PubMed ID: 8796908
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II.
Seissler J; Schott M; Steinbrenner H; Peterson P; Scherbaum WA
Exp Clin Endocrinol Diabetes; 1999; 107(3):208-13. PubMed ID: 10376448
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in adrenal autoimmunity.
Falorni A; Brozzetti A; Calcinaro F; Marzotti S; Santeusanio F
Expert Rev Endocrinol Metab; 2009 Jul; 4(4):333-348. PubMed ID: 30781285
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune Addison's Disease as Part of the Autoimmune Polyglandular Syndrome Type 1: Historical Overview and Current Evidence.
Perniola R; Fierabracci A; Falorni A
Front Immunol; 2021; 12():606860. PubMed ID: 33717087
[TBL] [Abstract][Full Text] [Related]
17. Heritability of Addison's disease and prevalence of associated autoimmunity in a cohort of 112,100 Swedish twins.
Skov J; Höijer J; Magnusson PKE; Ludvigsson JF; Kämpe O; Bensing S
Endocrine; 2017 Dec; 58(3):521-527. PubMed ID: 29039147
[TBL] [Abstract][Full Text] [Related]
18. The natural history of autoimmune Addison's disease with a non-classical presentation: a case report and review of literature.
Manso J; Pezzani R; Scarpa R; Gallo N; Betterle C
Clin Chem Lab Med; 2018 May; 56(6):896-900. PubMed ID: 29478039
[TBL] [Abstract][Full Text] [Related]
19. Autoimmunity to steroid-producing cells and familial polyendocrine autoimmunity.
Weetman AP
Baillieres Clin Endocrinol Metab; 1995 Jan; 9(1):157-74. PubMed ID: 7726795
[TBL] [Abstract][Full Text] [Related]
20. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease.
Betterle C; Volpato M; Rees Smith B; Furmaniak J; Chen S; Greggio NA; Sanzari M; Tedesco F; Pedini B; Boscaro M; Presotto F
J Clin Endocrinol Metab; 1997 Mar; 82(3):932-8. PubMed ID: 9062509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
